Article

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

2013-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 124c9683-b14e-5450-b3c6-6d0f332504bb
DOI: 10.1186/2051-1426-1-s1-p202
PMCID: PMC3991360

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)DOI 10.1186/2051-1426-1-s1-p202Read

Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells.Semantic proximity Read

Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.Semantic proximity Read

Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibodySemantic proximity Read

Fully human CD19-specific chimeric antigen receptors for T-cell therapySemantic proximity Read

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancerSemantic proximity Read

The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.Semantic proximity Read

An autocrine loop between TGF-β1 and the transcription factor brachyury controls the transition of human carcinoma cells into a mesenchymal phenotype.Semantic proximity Read

Selecting highly affine and well-expressed TCRs for gene therapy of melanomaSemantic proximity Read

Designer T cells by T cell receptor replacementSemantic proximity Read

Structures of the human transcription factor brachyury offer insights into DNA recognition, and identify small molecule binders for the development of degraders for cancer therapySemantic proximity Read